The Aemdee team has been so busy during the last six months in product development that blog posts have sadly been nonexistent. The good news is that our atrial fibrillation service is launching as we speak! In this blog post we thought that we’d describe what our new service provides for atrial fibrillation patients and the doctors treating them.
What is atrial fibrillation
In layman’s terms, atrial fibrillation is a condition of the heart where some portions of the heart do not operate correctly and the blood inside the heart may become immobile. Because blood inside the heart becomes immobile, blood clots start to appear. Via arteries leaving the heart, these clots may be transported to the brain causing blockades inside the brain, which is called a stroke. This is a life threatening situation that needs instant medical care. Many strokes lead to disabilities or death.
How is atrial fibrillation treated
A common treatment for atrial fibrillation patients is anticoagulation, which is a drug therapy that thins the blood so that blood clots would not appear. Older anticoagulants, like warfarin, are very difficult to maintain because they need constant monitoring of certain blood parameters. New anticoagulants, like dabigatran, rivaroxaban and apixaban, do not require monitoring and are therefore much easier to use.
What does Aemdee do for atrial fibrillation patients
Now we come to the part where Aemdee comes in. Even though the new anticoagulants don’t require monitoring, many doctors feel that they should be monitored in some way because the end result of non-compliance with treatment is so severe: a stroke. Aemdee’s atrial fibrillation monitoring service is meant to be used with the new anticoagulants to provide doctors and patients an automatic monitoring service. It actually does a whole lot more than just monitors pharmaceutical compliance, it monitors the patient’s condition with multiple parameters so that if the patient’s condition gets worse, the system automatically notifies health care providers so that they can react before something bad happens. Aemdee is meant to improve therapy and predict future adverse outcomes (=strokes).
Some more pros and features: it’s very easy to use, it reminds and notifies users automatically, it’s easy to start with patients, it’s cloud based and therefore available anywhere. Great stuff! We’re really proud to see it in use with atrial fibrillation patients!
Please send us an email if you’d like to learn more!